% Expired Patents = 71.4

Forward Citations = 794

Loading Chart...

4 inventors (with patents filed for the assignee):

John Daniel Dobak, Iii (4 out of 115 patents)

John D Dobak (2 out of 4 patents)

Hans Neisz (1 out of 3 patents)

4. Hugh Louis Narciso, Jr (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 7702386 - Nerve stimulation for treatment of obesity, metabolic syndrome, and Type 2 diabetes (2010-04-20),

2. 7689277 - Neural stimulation for treatment of metabolic syndrome and type 2 diabetes (2010-03-30),

3. 7689276 - Dynamic nerve stimulation for treatment of disorders (2010-03-30),

4. 7623924 - Devices and methods for gynecologic hormone modulation in mammals (2009-11-24),

5. 7551964 - Splanchnic nerve stimulation for treatment of obesity (2009-06-23),

6. 7239912 - Electric modulation of sympathetic nervous system (2007-07-03),

7. 7236822 - Wireless electric modulation of sympathetic nervous system (2007-06-26),

Company Overview

Leptos Biomedical, Inc. is a leading biotechnology company focused on developing innovative solutions for the diagnosis and treatment of neurological disorders. With a strong emphasis on research and development, Leptos is dedicated to improving the lives of patients through groundbreaking medical advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#3 in Fridley, MN

#1,122 in Minnesota

#39,929 in US

Fridley, MN, United States of America

Leptos Biomedical, Inc.

Forward Citations = 794

4 inventors:

John Daniel Dobak, Iii (4 out of 115 patents)

John D Dobak (2 out of 4 patents)

Hans Neisz (1 out of 3 patents)

4. Hugh Louis Narciso, Jr (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Leptos Biomedical, Inc.. Retrieved from https://idiyas.com/company/leptos-biomedical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]